Rezolute, Inc. Common Stock (NV)
Symbol: RZLT (NASDAQ)
Company Description:
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
- Today's Open: $5.81
- Today's High: $5.962
- Today's Low: $5.78
- Today's Volume: 377.12K
- Yesterday Close: $5.95
- Yesterday High: $6.2
- Yesterday Low: $5.921
- Yesterday Volume: 516.69K
- Last Min Volume: 1
- Last Min High: $5.8
- Last Min Low: $5.8
- Last Min VWAP: $5.8
- Name: Rezolute, Inc. Common Stock (NV)
- Website: https://www.rezolutebio.com
- Listed Date: 2011-12-23
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001509261
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $510.67M
- Round Lot: 100
- Outstanding Shares: 87.00M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-07-18 | 8-K | View |
2025-07-17 | S-3 | View |
2025-06-26 | 4 | View |
2025-06-24 | 4 | View |
2025-06-23 | 4 | View |
2025-06-23 | 4 | View |
2025-06-13 | 4 | View |
2025-06-13 | 8-K/A | View |
2025-06-13 | 8-K | View |
2025-06-13 | 4 | View |
2025-06-13 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-05-13 | 10-Q | View |
2025-05-13 | 8-K | View |
2025-04-28 | 8-K | View |
2025-04-23 | 8-K | View |